| Literature DB >> 31932377 |
Christopher R Miller1, Somrita Dey1, Paula D Smolenski1, Pushkar S Kulkarni1, Jonathan M Monk2, Richard Szubin2, George Sakoulas3,4, Andrew D Berti5,6.
Abstract
We present a case of endocarditis wherein organisms cultured from different valve leaflets yielded different daptomycin susceptibilities from each other and from organisms obtained from peripheral blood culture. Genomic analyses showed mutations in mprF, purR, and agrA Pharmacokinetic simulations showed consistent activity of daptomycin plus beta-lactam against all subpopulations. This represents an opportunity to understand S. aureus evolution and fitness in vivo on daptomycin therapy and the role of beta-lactams to prevent the selection of daptomycin-resistant subpopulations.Entities:
Keywords: MRSA; agr; combination therapy; daptomycin; endocarditis; fitness
Mesh:
Substances:
Year: 2020 PMID: 31932377 PMCID: PMC7038235 DOI: 10.1128/AAC.01593-19
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191